Acorda Thera (ACOR) Posts Q3 Loss of $0.51, 8c Better than Estimates
ACOR Hot Sheet
EPS Growth %: +350.0%Financial Fact:
Net loss per share-basic (earnings per share): 0.2
Today's EPS Names:
SAPX, ECTY, TRNS, More
Acorda Therapeutics (NASDAQ: ACOR) reports Q3 loss of $0.51, 8 cents better than the analyst estimate of ($0.59). Revenue for the quarter was $15.21 million, which compares to the estimate of $14.22 million.
You May Also Be Interested In
- UPDATE: Lowe's (LOW) Beats Q1 Views Amid Lagging Seasonal Demand; Issues Light FY12 Earnings Outlook
- Seven Arts Entmnt (SAPX) Narrows Q1 Loss to 5c/Share
- Sunlink Health Systems (SSY) Reports Q3 Loss of $0.13/Share
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
